Fresenius Kabi expands MicroVault packaging for Simplist morphine sulfate injection
Fresenius Kabi is releasing Simplist Morphine Sulfate Injection, in 2 mg per 1 mL and 4 mg per 1 mL ready-to-administer prefilled syringes in MicroVault packaging.
Morphine Sulfate Injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
MicroVault is next-generation packaging to support secure dispensing and diversion deterrence with hard plastic packaging and a tamper-evident seal. It also is designed to make narcotic inventory management easier with the use of 5-pack bundling and 10-pack cartons.
“We are focused on designing, developing and introducing products and labeling that support the safe dispensing of all products, but particularly controlled substances,” said John Ducker, president and CEO of Fresenius Kabi USA. “A MicroVault portfolio that now includes morphine is the latest example of our commitment to the secure dispensing of controlled substances.”
MicroVault packaging features include: Slim packaging that takes up less room than a blister pack in the locked compartments of automated dispensing cabinets; a diversion-deterrent polypropylene shell that is rigid and transparent, allowing bar code scanning and visual inspection; and a twist-to-open cap that facilitates access to the syringe.
The product is produced at the company’s advanced manufacturing center in North Carolina.